
Organization · Venture Capital
Norwich Ventures
Norwich Ventures is a specialized venture capital firm based in Waltham, Massachusetts, focusing on early-stage investments in the medtech sector. The firm targets technologies that address significant unmet medical needs.
Overview
What Norwich Ventures does
What Norwich Ventures is
Norwich Ventures is a specialized venture capital firm based in Waltham, Massachusetts, focusing on early-stage investments in the medtech sector. The firm targets technologies that address significant unmet medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2004
- Approximate age
- About 22 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Norwich Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Norwich Ventures as a funder
Investment thesis
Best-in-class medtech with capital-efficient approach, clear barriers to entry, and quick path to proof of concept. Focus on large unmet medical needs.
Focus narrative
Norwich Ventures invests in early-stage medtech companies across various fields of medicine, including electrophysiology, genomics, and women's health. The firm provides initial capital in seed and early-stage rounds and emphasizes a long-term investment perspective.
Value beyond capital
Norwich Ventures provides not only capital but also strategic guidance and industry connections to help portfolio companies navigate the complexities of the medtech landscape.
Focus and fit
- Stages
- Seed
- Sectors
- Healthcare
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Intelligent Bio-systems and Rhythmia Medical
Portfolio context
Notable past investments include companies that have been acquired by major firms such as Medtronic, Tempus, Qiagen, Laborie, Terumo, and Boston Scientific. Current portfolio companies include Affera (cardiac mapping/ablation), Arterys (medical imaging AI), IonPath (spatial biology/proteomics), Lexington Medical (surgical stapling), Podimetrics (diabetic foot monitoring), Vaxess (vaccine delivery), and Intelligent Bio-systems (DNA sequencing, acquired by Qiagen).
Connected ecosystem
Continue from Norwich Ventures
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Norwich Ventures
Upseed classifies Norwich Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.